INZY - Inozyme Pharma Inc
4
0.010 0.250%
Share volume: 1,459,443
Last Updated: 06-30-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$3.99
0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-05-2024 | 03-10-2025 | 05-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 24.345 M | 27.665 M | 24.851 M | 27.169 M | 25.788 M | |
| Selling general and admin | 5.234 M | 5.907 M | 4.961 M | 4.697 M | 5.409 M | |
| Research and development | 19.111 M | 21.758 M | 19.890 M | 22.472 M | 20.379 M | |
| Total expenses | 24.345 M | 27.665 M | 24.851 M | 27.169 M | 27.688 M | |
| 13.64% | -10.17% | 9.33% | 1.91% | |||
| Operating income | -24.345 M | -27.665 M | -24.851 M | -27.169 M | -27.688 M | |
| Ebit | -24.396 M | -27.668 M | -24.932 M | -27.136 M | -27.750 M | |
| Pretax income | -23.347 M | -27.033 M | -24.570 M | -27.074 M | -28.039 M | |
| 15.79% | -9.11% | 10.19% | 3.56% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -23.347 M | -27.033 M | -24.570 M | -27.074 M | -28.039 M | |
| -15.79% | 9.11% | -10.19% | -3.56% |